Literature DB >> 12365067

Evidence for the validity and reliability of the ALS assessment questionnaire: the ALSAQ-40.

C Jenkinson1, R Fitzpatrick, C Brennan, M Swash.   

Abstract

OBJECTIVES: The purpose of the study was to assess the validity and reliability of a new disease specific measure of health-related quality of life for ALS/MND: the 40-item ALS Assessment Questionnaire (ALSAQ-40).
DESIGN: We carried out a longitudinal postal survey. The two administrations of the questionnaire were separated by 3 months. SAMPLE: Subjects were patients diagnosed with ALS/MND and registered with the UK MND Association.
RESULTS: Dimensions of the ALSAQ-40 were shown to have high levels of internal reliability. The ALSAQ-40 was found to be sensitive to changes in self reported overall health state.
CONCLUSION: We concluded that the ALSAQ-40 has high levels of reliability and validity and can be used as an outcome measure in studies evaluating new treatment regimes and therapies.

Entities:  

Mesh:

Year:  1999        PMID: 12365067     DOI: 10.1080/146608299300080022

Source DB:  PubMed          Journal:  Amyotroph Lateral Scler Other Motor Neuron Disord        ISSN: 1466-0822


  17 in total

1.  A cross sectional study on determinants of quality of life in ALS.

Authors:  A Chiò; A Gauthier; A Montuschi; A Calvo; N Di Vito; P Ghiglione; R Mutani
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-11       Impact factor: 10.154

Review 2.  Clinical diagnosis and management of amyotrophic lateral sclerosis.

Authors:  Orla Hardiman; Leonard H van den Berg; Matthew C Kiernan
Journal:  Nat Rev Neurol       Date:  2011-10-11       Impact factor: 42.937

3.  Health-related quality of life in amyotrophic lateral sclerosis: determining a meaningful deterioration.

Authors:  Josephine M Norquist; Ray Fitzpatrick; Crispin Jenkinson
Journal:  Qual Life Res       Date:  2004-10       Impact factor: 4.147

4.  Reduced item set for the amyotrophic lateral sclerosis assessment questionnaire: development and validation of the ALSAQ-5.

Authors:  C Jenkinson; R Fitzpatrick
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-01       Impact factor: 10.154

5.  Deriving summary indices of health status from the Amyotrophic Lateral Sclerosis Assessment Questionnaires (ALSAQ-40 and ALSAQ-5).

Authors:  C Jenkinson; J M Norquist; R Fitzpatrick
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-02       Impact factor: 10.154

6.  Patients' health-related quality-of-life and health state values for motor neurone disease/amyotrophic lateral sclerosis.

Authors:  C Green; G Kiebert; C Murphy; J D Mitchell; M O'Brien; A Burrell; P N Leigh
Journal:  Qual Life Res       Date:  2003-08       Impact factor: 4.147

Review 7.  Therapeutic exercise for people with amyotrophic lateral sclerosis or motor neuron disease.

Authors:  Vanina Dal Bello-Haas; Julaine M Florence
Journal:  Cochrane Database Syst Rev       Date:  2013-05-31

8.  Effects of aerobic exercise therapy and cognitive behavioural therapy on functioning and quality of life in amyotrophic lateral sclerosis: protocol of the FACTS-2-ALS trial.

Authors:  Annerieke C van Groenestijn; Ingrid G L van de Port; Carin D Schröder; Marcel W M Post; Hepke F Grupstra; Esther T Kruitwagen; Harmen van der Linde; Reinout O van Vliet; Margreet G H van de Weerd; Leonard H van den Berg; Eline Lindeman
Journal:  BMC Neurol       Date:  2011-06-14       Impact factor: 2.474

9.  Validation of the Persian version of the 40-item amyotrophic lateral sclerosis assessment questionnaire.

Authors:  Hosein Shamshiri; Mohammad Reza Eshraghian; Nastaran Ameli; Shahriar Nafissi
Journal:  Iran J Neurol       Date:  2013

10.  Self perceived emotional functioning of spanish patients with amyotrophic lateral sclerosis: a longitudinal study.

Authors:  Jesús S Mora; Teresa Salas; María L Fajardo; Lourdes Iváñez; Francisco Rodríguez-Santos
Journal:  Front Psychol       Date:  2013-01-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.